Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
$ 1.91 -2.6%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Sangamo Therapeutics Balance Sheet 2011-2024 | SGMO

Annual Balance Sheet Sangamo Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-7.1 M -57.3 M -136 M -89.2 M -36 M -113 M -25.1 M -18.1 M -69.5 M -6.03 M -10.2 M -21.7 M -16.8 M

Long Term Debt

33.5 M 39 M 44.1 M - - - - - - - - - -

Long Term Debt Current

4.59 M 4.12 M - 3.69 M 3.21 M - - - - - - - -

Total Non Current Liabilities

- - - 298 M 135 M 145 M 54 M 8.4 M 4.7 M 15.7 M 9 M 8.85 M -

Total Current Liabilities

47.7 M 112 M 128 M 144 M 69.9 M 78.5 M 44.9 M 13.3 M 20.1 M 20.9 M 10.1 M 8.79 M 7.2 M

Total Liabilities

82.4 M 268 M 347 M 441 M 205 M 223 M 98.8 M 21.7 M 24.8 M 36.6 M 19.1 M 17.6 M 7.2 M

Deferred Revenue

- 51.8 M 85.7 M 96.6 M 38.7 M 47.6 M 28.3 M 4.14 M 9.12 M 9.05 M 2.28 M 2.3 M 148 K

Retained Earnings

-1.41 B -1.15 B -956 M -778 M -657 M -563 M -495 M -441 M -369 M -329 M -302 M -276 M -253 M

Total Assets

165 M 563 M 722 M 939 M 638 M 590 M 287 M 158 M 217 M 243 M 141 M 82.5 M 87.3 M

Cash and Cash Equivalents

45.2 M 100 M 180 M 131 M 80.4 M 140 M 49.8 M 22.1 M 69.5 M 6.03 M 10.2 M 21.7 M 16.8 M

Book Value

82.9 M 295 M 375 M 497 M 433 M 367 M 188 M 136 M 192 M 207 M 122 M 64.9 M 80.1 M

Total Shareholders Equity

82.9 M 295 M 375 M 498 M 433 M 367 M 188 M 136 M 192 M 207 M 122 M 64.9 M 80.1 M

All numbers in USD currency

Quarterly Balance Sheet Sangamo Therapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

27.7 M 29.1 M 35 M 36.4 M 37.7 M 39 M 39.7 M - 42.8 M 44.1 M 36.1 M 37.3 M 38.5 M 38.4 M 38.4 M 38.4 M 38.4 M 41.2 M 41.2 M 41.2 M 41.2 M - 27.7 M 27.7 M 27.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

72.1 M 69.3 M 84.8 M 91.4 M 105 M 268 M 285 M - 320 M 347 M 366 M 390 M 408 M 441 M 441 M 441 M 441 M 205 M 205 M 205 M 205 M 223 M 223 M 223 M 223 M 98.8 M 98.8 M 98.8 M 98.8 M 21.7 M 21.7 M 21.7 M 21.7 M 24.8 M 24.8 M 24.8 M 24.8 M 36.6 M 36.6 M 36.6 M 36.6 M 19.1 M 19.1 M 19.1 M 19.1 M 17.6 M 17.6 M 17.6 M 17.6 M 7.2 M 7.2 M 7.2 M 7.2 M

Deferred Revenue

774 K - 1.48 M 6.87 M 9.58 M 51.8 M 71.9 M - 80.8 M 85.7 M 90.5 M 94 M 94.4 M 91.6 M 91.6 M 91.6 M 91.6 M 38.7 M 38.7 M 38.7 M 38.7 M 47.6 M 47.6 M 47.6 M 35.2 M 28.3 M 28.4 M 29.5 M 3.6 M 4.14 M 4.14 M 4.14 M 4.14 M 9.12 M 9.12 M 9.12 M 9.12 M 9.05 M 9.05 M 9.05 M 9.05 M 2.28 M 2.28 M 2.28 M 2.28 M 2.3 M 2.3 M 2.3 M 2.3 M 17 K 17 K 17 K 17 K

Retained Earnings

-1.48 B -1.49 B -1.35 B -1.24 B -1.13 B -1.15 B -1.1 B - -1 B -956 M -919 M -871 M -824 M -778 M -778 M -778 M -778 M -657 M -657 M -657 M -657 M -563 M -563 M -563 M -563 M -495 M -495 M -495 M -495 M -441 M -441 M -441 M -441 M -369 M -369 M -369 M -369 M -329 M -329 M -329 M -329 M -302 M -302 M -302 M -302 M -276 M -276 M -276 M -276 M -253 M -253 M -253 M -253 M

Total Assets

111 M 93 M 220 M 325 M 441 M 563 M 594 M - 654 M 722 M 772 M 835 M 877 M 939 M 939 M 939 M 939 M 638 M 638 M 638 M 638 M 590 M 590 M 590 M 590 M 287 M 287 M 287 M 287 M 158 M 158 M 158 M 158 M 217 M 217 M 217 M 217 M 243 M 243 M 243 M 243 M 141 M 141 M 141 M 141 M 82.5 M 82.5 M 82.5 M 82.5 M 87.3 M 87.3 M 87.3 M 87.3 M

Cash and Cash Equivalents

39.2 M 27.8 M 56.5 M 66.8 M 78.2 M 100 M 94.6 M 118 M 120 M 179 M 177 M 170 M 123 M 131 M 131 M 131 M 131 M 80.4 M 80.4 M 80.4 M 80.4 M 140 M 140 M 140 M 140 M 49.8 M 49.8 M 49.8 M 49.8 M 22.1 M 22.1 M 22.1 M 22.1 M 69.5 M 69.5 M 69.5 M 69.5 M 6.03 M 6.03 M 6.03 M 6.03 M 10.2 M 10.2 M 10.2 M 10.2 M 21.7 M 21.7 M 21.7 M 21.7 M 16.8 M 16.8 M 16.8 M 16.8 M

Book Value

39.1 M 23.7 M 135 M 234 M 336 M 295 M 309 M - 335 M 375 M 406 M 445 M 469 M 497 M 497 M 497 M 497 M 433 M 433 M 433 M 433 M 367 M 367 M 367 M 367 M 188 M 188 M 188 M 188 M 136 M 136 M 136 M 136 M 192 M 192 M 192 M 192 M 207 M 207 M 207 M 207 M 122 M 122 M 122 M 122 M 64.9 M 64.9 M 64.9 M 64.9 M 80.1 M 80.1 M 80.1 M 80.1 M

Total Shareholders Equity

39.1 M 23.7 M 135 M 234 M 336 M 295 M 309 M 318 M 335 M 375 M 406 M 445 M 470 M 498 M 498 M 498 M 498 M 433 M 433 M 433 M 433 M 367 M 367 M 367 M 367 M 188 M 188 M 188 M 188 M 136 M 136 M 136 M 136 M 192 M 192 M 192 M 192 M 207 M 207 M 207 M 207 M 122 M 122 M 122 M 122 M 64.9 M 64.9 M 64.9 M 64.9 M 80.1 M 80.1 M 80.1 M 80.1 M

All numbers in USD currency